drugset
drugset / Trial / NCT03713801

Impact of Metformin on Immunity

NCT03713801 ↗

Phase 1 Completed 18 enrolled The University of Texas Health Science Center at San Antonio
RandomizedParallel-groupTriple-blindBasic science

Summary

To determine whether metformin (MET) can improve the immune response to the pneumococcal conjugate vaccine (PCV-13) in older adults.

Timeline

Start
2019-01-14
Primary completion
2024-07-16
Completion
2024-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1500 mg Oral

Indications

No indication recorded.